Showing results (31-40 of 47) with videos related to
Sort By:
Pageof 5
Hypertension (Dallas, Tex. : 1979)|December 7, 2016
Chronic Inhibition of Renal Outer Medullary Potassium Channel Not Only Prevented but Also Reversed Development of Hypertension and End-Organ Damage in Dahl Salt-Sensitive RatsXiaoyan Zhou, Michael J Forrest, Wanda Sharif-Rodriguez, et al.Journal of Cardiovascular Translational Research|December 24, 2011
Comparison of lipoprotein separation and lipid analysis methodologies for human and cynomolgus monkey plasma samplesSeongah Han, Amy M Flattery, David McLaren, et al.Mabs|January 16, 2010
IgG2m4, an engineered antibody isotype with reduced Fc functionZhiqiang An, Gail Forrest, Renee Moore, et al.Diabetes|October 9, 2013
Genetic deletion and pharmacological inhibition of phosphodiesterase 10A protects mice from diet-induced obesity and insulin resistanceAndrea R Nawrocki, Carlos G Rodriguez, Dawn M Toolan, et al.Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology|March 23, 2024
Corticospinal inhibition investigated in relation to upper extremity motor function in cervical spinal cord injuryTarun Arora, Jia Liu, Akhil Mohan, et al.Journal of Neurotrauma|May 24, 2023
Profiling Immunological Phenotypes in Individuals During the First Year After Traumatic Spinal Cord Injury: A Longitudinal AnalysisDebra Morrison, Camille Pinpin, Annette Lee, et al.Journal of Neurotrauma|September 22, 2025
Acute Immunological Phenotypes in Individuals with Traumatic Spinal Cord InjuryDebra Morrison, Camille Pinpin, Annette Lee, et al.European Journal of Pharmacology|April 29, 2014
Effects of anacetrapib on plasma lipids, apolipoproteins and PCSK9 in healthy, lean rhesus macaquesThomas P Roddy, David G McLaren, Ying Chen, et al.Journal of Lipid Research|October 7, 2016
Dose-dependent effects of siRNA-mediated inhibition of SCAP on PCSK9, LDLR, and plasma lipids in mouse and rhesus monkeyKristian K Jensen, Marija Tadin-Strapps, Sheng-Ping Wang, et al.Obesity (Silver Spring, Md.)|May 15, 2013
Pharmacological inhibition of diacylglycerol acyltransferase 1 reduces body weight and modulates gut peptide release--potential insight into mechanism of actionJinqi Liu, Judith N Gorski, Stephen J Gold, et al.Pageof 5